LEGNLegend Biotech Corp
- Market cap
- $3.75B
- as of 2026-10-23
- Latest close
- $19.27
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-03-27
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. | Sep 29 | Oct 1 | S | 27,370 | $9.46 | Sale −$258,920 | 52,731 | No | Form 4 |
| Sanders Corazon (Corsee) D. | Sep 24 | Sep 28 | A | 20,986 | $0.00 | $0 | 80,101 | No | Form 4 |
| Heyman Tomas J. | Sep 24 | Sep 28 | A | 20,986 | $0.00 | $0 | 53,720 | No | Form 4 |
| Ji Darren Xiaohui | Sep 24 | Sep 28 | A | 28,330 | $0.00 | $0 | 92,103 | No | Form 4 |
| Casey Patrick John | Sep 24 | Sep 28 | A | 20,986 | $0.00 | $0 | 69,590 | No | Form 4 |
| Salovey Peter | Sep 24 | Sep 28 | A | 28,330 | $0.00 | $0 | 55,096 | No | Form 4 |
| Mao Li | Sep 24 | Sep 28 | A | 20,986 | $0.00 | $0 | 65,316 | No | Form 4 |
| Santos Carlos EChief Financial Officer | Sep 21 | Sep 23 | A | 19,676 | $0.00 | $0 | 19,676 | No | Form 4 |
| Santos Carlos EChief Financial Officer | Sep 21 | Sep 23 | S | 5,430 | $9.14 | Sale −$49,630 | 14,246 | No | Form 4 |
| Zhang IngridChief Executive Officer | Sep 15 | Sep 16 | A | 1,131,860 | $0.00 | $0 | 1,131,860 | No | Form 4 |
| Bash AlanInterim CEO | Aug 14 | Aug 18 | A | 4,908 | $0.00 | $0 | 35,142 | No | Form 4 |
| Huang YingChief Executive Officer | Jun 30 | Jul 2 | G | 3,382 | $0.00 | $0 | 238,490 | No | Form 4 |
| Casey Patrick John | Jun 30 | Jul 2 | S | 6,000 | $14.80 | Sale −$88,800 | 48,604 | No | Form 4 |
| Huang YingChief Executive Officer | Jun 25 | Jun 29 | S | 5,566 | $14.78 | Sale −$82,265 | 241,872 | No | Form 4 |
| Huang YingChief Executive Officer | Mar 25 | Mar 27 | S | 9,936 | $8.77 | Sale −$87,139 | 247,438 | No | Form 4 |